Effect of Flowable Thrombin-Containing Collagen-Based Hemostatic Matrix for Preventing Pancreatic Fistula after Pancreatectomy: A Randomized Clinical Trial
- PMID: 32987876
- PMCID: PMC7601002
- DOI: 10.3390/jcm9103085
Effect of Flowable Thrombin-Containing Collagen-Based Hemostatic Matrix for Preventing Pancreatic Fistula after Pancreatectomy: A Randomized Clinical Trial
Abstract
Background: The aim of this study was to evaluate the safety and efficacy of a flowable hemostatic matrix, and their effects for postoperative pancreatic fistula (POPF) after pancreatectomy.
Methods: This was a randomized, clinical, single-center, single-blind (participant), non-inferiority, phase IV, and parallel-group trial. The primary endpoint was the incidence of POPF. The secondary endpoints were risk factors for POPF, drain removal days, incidence of complication, 90-day mortality, and length of hospital stay.
Results: This study evaluated a total of 53 patients, of whom 26 patients were in the intervention group (flowable hemostatic matrix) and 27 patients were in the control group (thrombin-coated collagen patch). POPF was more common in the control group than in the intervention group (59.3% vs. 30.8%, p = 0.037). Among participants who underwent distal pancreatectomy, POPF (33.3% vs. 92.3%, p = 0.004), and clinically relevant POPF (8.3% vs. 46.2%, p = 0.027) was more common in the control group. A multivariate logistic regression model identified flowable hemostatic matrix use as an independent negative risk factor for POPF, especially in cases of distal pancreatectomy (DP) (odds ratio 17.379, 95% confidential interval 1.453-207.870, p = 0.024).
Conclusion: Flowable hemostatic matrix application is a simple, feasible, and effective method of preventing POPF after pancreatectomy, especially for patients with DP. Non-inferiority was demonstrated in the efficacy of preventing POPF in the intervention group compared to the control group.
Keywords: pancreatectomy; pancreatic fistula; pancreatic neoplasm.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Kimura W., Miyata H., Gotoh M., Hirai I., Kenjo A., Kitagawa Y., Shimada M., Baba H., Tomita N., Nakagoe T., et al. A Pancreaticoduodenectomy Risk Model Derived From 8575 Cases From a National Single-Race Population (Japanese) Using a Web-Based Data Entry System The 30-Day and In-hospital Mortality Rates for Pancreaticoduodenectomy. Ann. Surg. 2014;259:773–780. doi: 10.1097/SLA.0000000000000263. - DOI - PubMed
-
- Song K.B., Kim S.C., Hwang D.W., Lee J.H., Lee D.J., Lee J.W., Park K.M., Lee Y.J. Matched Case-Control Analysis Comparing Laparoscopic and Open Pylorus-preserving Pancreaticoduodenectomy in Patients With Periampullary Tumors. Ann. Surg. 2015;262:146–155. doi: 10.1097/SLA.0000000000001079. - DOI - PubMed
LinkOut - more resources
Full Text Sources
